Skip to main content
. 2010 Dec;42(6):358–361. doi: 10.4103/0253-7613.71916

Table 3.

Comparison of disease activity score (mean ±SD)

MTX + HCQ (Min.-Max.) LEF (Min.-Max.) P
Baseline 6.42 ± 1.74 (VA) (1–8) 6.91 ± 1.19 (VA) (3–7) 0.453
Sixth week 5.00 ± 1.61 (MA) (1–8) 5.30 ± 1.28 (MA) (3–7) 0.601
Twelfth week 3.37 ± 0.84 (MA) (1–5) 3.61 ± 0.63 (MA) (2–5) 0.266
P <0.001* <0.001*

Disease activity: VA, very active; MA, moderate active;

*

Statistically significant; MTX = Methotrexate; HCQ = hydroxychloroquine; LEF = leflunomide